Vaccination with the defined chlamydial secreted protein CPAF induces robust protection against female infertility following repeated genital chlamydial challenge

Vaccine

Volumn 29, Issue 14, 2011, Pages 2519-2522

  Murthy, Ashlesh K ^a   Li, Weidang ^a   Guentzel, M Neal ^a   Zhong, Guangming ^b   Arulanandam, Bernard P ^a  

^a UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Chlamydia; Chlamydial protease like activity factor; Fertility; Genital infection; Infertility; Intranasal; Repeated infections; Secondary challenge; Vaccine

Indexed keywords

CPG OLIGODEOXYNUCLEOTIDE; RECOMBINANT CHLAMYDIAL PROTEASE LIKE ACTIVITY FACTOR; RECOMBINANT VACCINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CHLAMYDIA; CHLAMYDIASIS; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FEMALE INFERTILITY; HYDROSALPINX; MOUSE; NONHUMAN; PRIORITY JOURNAL; VACCINATION;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, INTRANASAL; ANIMALS; BACTERIAL VACCINES; CHLAMYDIA INFECTIONS; ENDOPEPTIDASES; FEMALE; INFERTILITY, FEMALE; MICE; MICE, INBRED BALB C; OLIGODEOXYRIBONUCLEOTIDES; VACCINATION;

EID: 79952252416     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.01.074     Document Type: Article

References (13)

1. Brunham R.C., Rey-Ladino J. Immunology of Chlamydia infection: implications for a Chlamydia trachomatis vaccine. Nat Rev Immunol 2005, 5(February (2)):149-161.
2. Morrison R.P., Caldwell H.D. Immunity to murine chlamydial genital infection. Infect Immun 2002, 70(June (6)):2741-2751.
3. Murthy A.K., Chambers J.P., Meier P.A., Zhong G., Arulanandam B.P. Intranasal vaccination with a secreted chlamydial protein enhances resolution of genital Chlamydia muridarum infection, protects against oviduct pathology, and is highly dependent upon endogenous gamma interferon production. Infect Immun 2007, 75(February (2)):666-676.
4. Cong Y., Jupelli M., Guentzel M.N., Zhong G., Murthy A.K., Arulanandam B.P. Intranasal immunization with chlamydial protease-like activity factor and CpG deoxynucleotides enhances protective immunity against genital Chlamydia muridarum infection. Vaccine 2007, 25(May (19)):3773-3780.
5. Chaganty B.K., Murthy A.K., Evani S.J., Li W., Guentzel M.N., Chambers J.P., et al. Heat denatured enzymatically inactive recombinant chlamydial protease-like activity factor induces robust protective immunity against genital chlamydial challenge. Vaccine 2010, 28(March (11)):2323-2329.
6. Murthy A.K., Sharma J., Coalson J.J., Zhong G., Arulanandam B.P. Chlamydia trachomatis pulmonary infection induces greater inflammatory pathology in immunoglobulin A deficient mice. Cell Immunol 2004, 230(July (1)):56-64.
7. Murthy A.K., Cong Y., Murphey C., Guentzel M.N., Forsthuber T.G., Zhong G., et al. Chlamydial protease-like activity factor induces protective immunity against genital chlamydial infection in transgenic mice that express the human HLA-DR4 allele. Infect Immun 2006, 74(December (12)):6722-6729.
8. + T cells. Cell Immunol 2006, 242(August (2)):110-117.
9. Li W., Guentzel M.N., Seshu J., Zhong G., Murthy A.K., Arulanandam B.P. Induction of cross-serovar protection against genital chlamydial infection by a targeted multisubunit vaccination approach. Clin Vaccine Immunol 2007, 14(December (12)):1537-1544.
10. + T cells produce sufficient IFN-gamma to mediate robust protective immunity against genital Chlamydia muridarum infection. J Immunol 2008, 180(March (5)):3375-3382.
11. Murthy A.K., Chaganty B.K., Li W., Guentzel M.N., Chambers J.P., Seshu J., et al. A limited role for antibody in protective immunity induced by rCPAF and CpG vaccination against primary genital Chlamydia muridarum challenge. FEMS Immunol Med Microbiol. 2009, 55(March (2)):271-279.
12. Debattista J., Timms P., Allan J., Allan J. Immunopathogenesis of Chlamydia trachomatis infections in women. Fertil Steril 2003, 79(June (6)):1273-1287.
13. Dong F., Zhong Y., Arulanandam B., Zhong G. Production of a proteolytically active protein, chlamydial protease/proteasome-like activity factor, by five different Chlamydia species. Infect Immun 2005, 73(March (3)):1868-1872.